(Q38968369)

8 September 2017

0 references

1 reference

title

The association between the gut microbiota and the inflammatory bowel disease activity: a systematic review and meta-analysis (English)

1 reference

inflammatory bowel diseases

8 September 2017

0 references

1 reference

1 reference

Andreas Munk Petersen

object named as

Andreas M Petersen

4

0 references

Lise L Gluud

object named as

Lise L Gluud

5

0 references

author name string

Michelle Prosberg

1

1 reference

PubMed ID

27687331

8 September 2017

Flemming Bendtsen

2

1 reference

PubMed ID

27687331

8 September 2017

Ida Vind

3

1 reference

8 September 2017

9 August 2016

1 reference

Scandinavian Journal of Gastroenterology

8 September 2017

1 reference

8 September 2017

51

1 reference

8 September 2017

12

1 reference

8 September 2017

1407-1415

1 reference

Pathological and therapeutic interactions between bacteriophages, microbes and the host in inflammatory bowel disease

8 September 2017

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

The microbiome in inflammatory bowel disease: current status and the future ahead

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

Disease course and surgery rates in inflammatory bowel disease: a population-based, 7-year follow-up study in the era of immunomodulating therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

Immunopathology of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

The fundamental basis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

Genetics and pathogenesis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

Metagenomic analysis of the human distal gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

Demystifying fixed and random effects meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

Fecal microbial transplant via nasogastric tube for active pediatric ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

Colonisation by Faecalibacterium prausnitzii and maintenance of clinical remission in patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

Increased proportions of Bifidobacterium and the Lactobacillus group and loss of butyrate-producing bacteria in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

The biodiversity and composition of the dominant fecal microbiota in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

Gram-negative bacteria account for main differences between faecal microbiota from patients with ulcerative colitis and healthy controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

Low counts of Faecalibacterium prausnitzii in colitis microbiota.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

Fluctuations in butyrate-producing bacteria in ulcerative colitis patients of North India

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

Association of gut microbiota with post-operative clinical course in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

Association between specific mucosa-associated microbiota in Crohn's disease at the time of resection and subsequent disease recurrence: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

Longitudinal analyses of gut mucosal microbiotas in ulcerative colitis in relation to patient age and disease severity and duration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

Dynamics of the mucosa-associated flora in ulcerative colitis patients during remission and clinical relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

Mucosa-associated Faecalibacterium prausnitzii and Escherichia coli co-abundance can distinguish Irritable Bowel Syndrome and Inflammatory Bowel Disease phenotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

Clostridium leptum group bacteria abundance and diversity in the fecal microbiota of patients with inflammatory bowel disease: a case-control study in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

The immunological and genetic basis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

A core gut microbiome in obese and lean twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

Crohn's as an immune deficiency: from apparent paradox to evolving paradigm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

Diet, microbes, and host genetics: the perfect storm in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

Specificities of the fecal microbiota in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

Host-Mediated Inflammation Disrupts the Intestinal Microbiota and Promotes the Overgrowth of Enterobacteriaceae

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1216587

10.1080/00365521.2016.1216587

21 January 2018

Identifiers

DOI

1 reference

8 September 2017

1 reference

PubMed ID

27687331